(No ratings)
Dr. Marie Bleakley, PhD, MD, MPH, MMSc is a medical oncologist in Seattle, WA specializing in medical oncology, adult oncology, pediatric hematology/oncology and general pediatrics. She graduated from Flinders University School of Medicine. Dr. Marie Bleakley, PhD, MD, MPH, MMSc is affiliated with University of Washington (UW) Medicine and Seattle Children's.
1100 Fairview Avenue N Po Box 19024 - Ms D3-100
Seattle, WA 98109
1354 Aloha Street
Seattle, WA 98109
4800 Sand Point Way Ne
Seattle, WA 98105
Dr. Marie Bleakley, PhD, MD, MPH, MMSc graduated from Flinders University School of Medicine. She is certified by the Board Certification: Pediatric Hematology-Oncology and has a state license in Washington.
Medical School: Flinders University School of Medicine
Board Certification: Board Certification: Pediatric Hematology-Oncology
Licensed In: Washington
Dr. Marie Bleakley, PhD, MD, MPH, MMSc is associated with these hospitals and organizations:
Dr. Marie Bleakley, PhD, MD, MPH, MMSc does not have any reviews yet, be the first to leave a review of Dr. Marie Bleakley, PhD, MD, MPH, MMSc here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Marie Bleakley, PhD, MD, MPH, MMSc. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Pfizer Inc. |
$12,818
$12,818 |
---|---|
Eli Lilly and Company |
$190
$190 |
Alexion Pharmaceuticals, Inc. |
$23
SOLIRIS $23 |
Grant | $12,818 |
---|---|
Food and Beverage | $213 |
Dr. Marie Bleakley practices adult oncology, pediatric hematology/oncology, and medical oncology in Seattle, WA. Clinical interests for Dr. Bleakley include cancer and blood disorders. She is professionally affiliated with the University of Washington (UW) Medicine and Seattle Children's. Dr. Bleakley is a graduate of Flinders University School of Medicine, Newcastle University Faculty of Medical Sciences, and The University of Sydney Medical School. She has received professional recognition including the following: Karl Blume Award and Best Clinical Science Article by a New Investigator - ASTCT.